Abstract

Melanomas affecting the small bowel are usually metastasis from primary cutaneous lesions. A primary melanoma of the gastrointestinal tract is very rare with reported incidence of just 3%. We present a case of small bowel melanoma with liver metastases. Primary malignant melanoma of the small intestine is quite rare with only a few cases reported in literature. Like its cutaneous counterpart, intestinal melanomas too remains an aggressive disease with a poor prognosis. The overall survival of malignant melanoma affecting the GI tract is 4 to 6 months with a survival rate of less than 10% at 5 years.

Highlights

  • Malignant melanoma develops from melanocytes which are usually located in the skin, the eye’s choroid, the meninges, and the anal margin

  • Primary malignant melanoma of the small intestine is quite rare, only a handful of cases have been reported in literature

  • The origin primary melanoma of small intestine is because of the melanoblastic cells of the neural crest that migrate to the distal ileum through the omphalomesenteric canal There these cells differentiate by amine precursor uptake and decarboxylation (APUD), and can undergo neoplastic transformation in non-cutaneous site,[1] some authors still deny the existence of primary melanoma in the gastrointestinal tract

Read more

Summary

Introduction

Malignant melanoma develops from melanocytes which are usually located in the skin, the eye’s choroid, the meninges, and the anal margin. Melanoma of the GI tract represents 1 to 3% of the digestive tract cancers.[1] Primary malignant melanoma of the small intestine is quite rare, only a handful of cases have been reported in literature. Intestinal melanoma too remains an aggressive disease with a poor prognosis. We present a rare case report of a 48 year old man who presented with pain in abdomen and weight loss. He already had underwent an ultrasound of the abdomen which was suspicious of liver metastases, before being referred to our side for further management

Case Report
Findings
Discussion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.